MARSHALL WACE, LLP

Position in STRO — Sutro Biopharma, Inc.

CIK 1318757 LONDON, X0

Position in STRO

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$5,818,166

+$272,354 QoQ

Shares Held

175,246

-21.3% QoQ

Ownership

1.06%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#26

of 97 holders

Holding Since

Dec 2020

13 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. STRO ranks #93 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	543,897	$270,169,956
2	INCY	Incyte Corp	1,310,154	$148,519,056
3	RPRX	Royalty Pharma plc	2,450,669	$137,409,009
4	SYRE	Spyre Therapeutics, Inc.	991,693	$88,042,503
5	ALNY	Alnylam Pharmaceuticals, Inc.	259,799	$78,207,292
6	TVTX	Travere Therapeutics, Inc.	1,333,207	$75,739,488
7	MANE	Veradermics, Inc	585,560	$71,988,746
8	DFTX	Definium Therapeutics, Inc.	1,298,946	$61,102,419

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,818,166	175,246	-21.3%	Shares	Other	2026-08-13
2026-03-31	$5,545,812	222,634	+160.0%	Shares	Other	2026-05-15
2025-12-31	$990,565	85,615	-27.7%	Shares	Other	2026-02-13
2025-09-30	$103,045	118,443	-49.5%	Shares	Other	2025-11-13
2025-06-30	$166,445	234,431	+664.6%	Shares	Other	2025-08-13
2024-09-30	$106,087	30,661	-85.9%	Shares	Other	2024-11-14
2023-03-31	$1,006,721	217,905	-61.1%	Shares	Other	2023-05-15
2022-12-31	$4,524,113	559,915	+6.9%	Shares	Other	2023-02-14
2022-09-30	$2,906,096	523,621	-8.8%	Shares	Other	2022-11-14
2022-06-30	$2,991,785	574,239	+399.8%	Shares	Other	2022-08-15
2021-06-30	$2,135,898	114,895	-64.1%	Shares	Sole	2021-08-13
2021-03-31	$7,293,305	320,444	+2.3%	Shares	Sole	2021-05-17
2020-12-31	$6,797,401	313,100	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.